Note 5. Inventories

The components of inventories are as follows:

	December 31, 2015		March 31, 2015
	(in $000's)
Raw materials and supplies	$	8,894	$	7,417
Work-in-progress		10,427		6,466
Finished goods		6,214		2,891
	$	25,535	$	16,774

The Company’s inventories relate to its circulatory care product lines, primarily its Impella® heart pump product platforms. Finished goods and work-in-process inventories consist of direct material, labor and overhead. During the three and nine months ended December 31, 2015, the Company recorded $0.4 million and $1.4 million, respectively, in write-downs of inventory. During the three and nine months ended December 31, 2014, the Company recorded $0.6 million and $1.1 million, respectively, in write-downs of inventory.